Clinical trials
Phase 2 Heart Failure trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Terminated | 3 |
| Unknown status | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 3 |
| Cardurion Pharmaceuticals, Inc. | 2 |
| AstraZeneca | 1 |
| Australian and New Zealand Intensive Care Research Centre | 1 |
| Cytokinetics | 1 |
| Flinders University | 1 |
| Mast Therapeutics, Inc. | 1 |
| Monash University | 1 |
| National University Hospital, Singapore | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 16 |
| Cardiovascular Diseases | 2 |
| Heart Diseases | 2 |
| Cardiomyopathy, Hypertrophic | 1 |
| Critical Illness | 1 |
| Dyspnea | 1 |
| Heart Failure, Diastolic | 1 |
| Hyperoxia | 1 |
| Hypersensitivity | 1 |
| Hypertrophy | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.